STUDY OF EXPRESSION OF HBD-1 AND HBD-2 GENES IN EPITHELIAL CELLS OF MUCOUS UPPER AIRWAY IN NEWBORNS WITH PNEUMONIA DEPENDING ON THE CAUSATIVE AGENT

Cover Page

Cite item

Full Text

Abstract

Β-defensins play an important role in protecting the fetus from infection, so the expression of these antimicrobial peptides in the respiratory tract in newborns is really important. In this regard, we set a task of studying the expression of the HBD-1 and HBD-2 genes in the epithelial cells of the mucous of the upper airway in newborns with pneumonia and in healthy newborns, depending on the causative agent. Also, the polymorphic marker G(-20) A in the DEFB1 gene was associated with infectious pathology of newborns (in particular pneumonia). Methods: The microflora and the factors of congenital immunity on the mucous membranes of the upper airway have been studied in two groups: newborns with ventilator-associated and congenital pneumonia. The biological material was scrapings of epithelial cells of the mucous membrane of the upper airway of newborns and puerperas and blood. Results: It was found that the expression of the HBD-2 gene increases 2.3-fold in children who have an infectious agent, but there are no clinical manifestations of pneumonia. A significant decrease in HBD-2 (3.2 times) in patients with pneumonia caused by K. pneumonia was shown. The frequencies of alleles of the DEFB1 gene in the fetal infection group and in the comparison group: allele G - 0.66, 0.79, allele A - 0.34, 0.21, respectively. The frequencies of the genotypes of the test marker in mothers in the ventilator-associated, congenital pneumonia and the comparison group were as follows: GG - 0.78, 0.58, 0.58; AA is 0, 0.25, 0; AG - 0.22, 0.17, 0.42, respectively. In newborns allele G dominated among alleles (frequency was higher than 0.73 in all groups) and genotype GG (frequency exceeded 0.52). Conclusion: In the course of the study, it was confirmed that β-defensins protect the mucous from infectious agents. The results indicate that the genetic marker G (-20) A of the DEFB1 gene is associated with the risk of developing the child's UTI.

About the authors

N D Rasskazova

Mechnikov Institute of Vaccines and Sera

Author for correspondence.
Email: svitichoa@yandex.ru

A I Alieva

Dagestan State Medical University

Email: svitichoa@yandex.ru

L V Gankovskaya

Pirogov Russian National Research Medical University

Email: svitichoa@yandex.ru

P V Zhigalkina

Mechnikov Institute of Vaccines and Sera; Sechenov Medical University

Email: svitichoa@yandex.ru

O A Svitich

Mechnikov Institute of Vaccines and Sera; Pirogov Russian National Research Medical University; Sechenov Medical University

Email: svitichoa@yandex.ru

corresponding member RAS, MD

References

  1. Fayon M.J. et al. Nosocomial pneumonia and tracheitis in a pediatric intensive care unit: a prospective study. American Journal of Respiratory and Critical Care Medicine. 1997. V. 155. № 1.
  2. Wang Y.J., Liu J., Fang F. et al. Microbiological etiology in children with community acquired pneumonia. Zhongguo Dang Dai ErKeZaZhi. 2010. Vol. 12, No. 3. P. 184—187.
  3. Svitich O.A., Alieva A.I., Rasskazova N.D., Semenova E.A., Malushenko S.V., Gankovskaya L.V. Study of association of polymorphic markers in the genes TLR9, TNF, and DEFB1 c premature birth of infectious genesis and with the development of pneumonia in newborns. Russian Immunological Journal. 2014. Vol. 8 (17). No 3. C. 871—873.
  4. Liu L., Oza S., Hogan D., Chu Y., Perin J., Zhu J., et al. Global, regional, and national causes of under-5 mortality in 2000—15: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet. 2016; 388 (10063): 3027—3035. doi: 10.1016/S0140-6736(16)31593-8.
  5. Becker-Dreps S., Blette B., Briceño R., Alema'n J., Hudgens M.G., Moreno G., et al. (2017) Changes in the incidence of pneumonia, bacterial meningitis, and infant mortality 5 years of the introduction of the 13-valent pneumococcal conjugate vaccine in a “3 + 0” schedule. PLoS ONE 12 (8): e0183348. https://doi.org/10.1371/ journal.pone.0183348.
  6. Alieva A.I., Svitich O.A., Rasskazova N.D., Gankovskaya L.V. Clinico-microbiological and immunological (TLR2, TLR4) features of newborns on artificial ventilation. Uchenyezapiski Orel State University. 2014. No. 7 (63). C. 116—117.
  7. Khashukoyeva A.Z., Svitich O.A., Markova E.A., Otchitnova O.B., Khlynova S.A. Photodynamic therapy — antiviral therapy? Background of the issue. Prospects of application. Laser medicine. 2012. T. 16. № 2. P. 63—67.
  8. Labzhinov P.A., Svitich O.A., Gankovskaya L.V., Zverev V.V. Evaluation of the expression of the genes of components of innate immunity in leukocytes of mice with the action of synthetic ligands in vivo. Journal of Microbiology, Epidemiology and Immunobiology. 2013. No. 6. P. 76—80.
  9. Gankovskaya L.V., et al. Innate immunity gene expression by epithelial cells of the upper respiratory tract in children with adenoid hypertrophy. AurisNasus Larynx (2018) https://doi.org/10.1016/j.anl.2017.11.011.
  10. Gankovskaya L.V., Kovalchuk L.V., Guseva M.R., Gankovskaya O.A., Vorobyova J.A., Dzhambinova N.S., Gavrilova Т.V. Expression of tlr9 and hbd-2 genes by conjunctival and corneal cells in children with arboreal herpetic keratitis. Herald of Ophthalmology. 2010. T. 126. № 5. P. 13—16.
  11. Alieva A.I., Svitich O.A., Omarova S.M., Kasumova A.M. Clinical microbiological and immunological justification of ventilator-associated pneumonias in newborns. Russian Immunological Journal. 2015. Vol. 9 (18), No. 2 (1). C. 184—185.
  12. Semenova E.A., Svitich O.A., Alieva A.I., Gankovskaya L.V. Study of the association of polymorphic markers in the TNFA, IL-10 and IL-17 genes with the development of intrauterine infection of the fetus and pneumonia in newborns. Russian Journal of Immunology. 2015. Vol. 9 (18), Number 1 (1). C. 169—171.
  13. Gankovskaya O.A., Bakhareva I.V., Gankovskaya L.V., Zverev V.V. Association of polymorphic markers G (-20) A, C (-44) G and G (-52) A of the DEFβ1 gene with the development of preterm birth and intrauterine infection of the fetus. Russian Journal of Immunology. 2011. T. 5. № 1 (14). P. 26—33.
  14. Gankovskaya O.A., Gankovskaya L.V., Lavrov V.F., Kovalchuk L.V. Expression of TLR-9 and production of cytokines by mononuclear cells of patients with genital herpes. Medical immunology. 2006. T. 8. № 2—3. C. 255.
  15. Svitich O.A., Alieva A.I., Semenova E.A., Malushenko S.V., Rusanova K.V. Association of polymorphic markers in the genes TLR9, TNF and DEFB1 with the development of pneumonia in newborns. Uchenye zapiski Orel State University. 2014. No. 7 (63). C. 153—154.
  16. Jurevic R.J., Chrisman P., Mancl L. et al. Single-nucleotide polymorphisms and haplotype analysis in beta-defensin genes in different ethnic populations. Genet. Test. 2002. 6 (4). P. 261—9.
  17. Lavrov V.F., Gankovskaya O.A., Krivtsov G.G. A promising model for testing the functions of toll-like receptors in vitro. Physiology and pathology of the immune system. 2009. T. 13. № 12. P. 3—6.
  18. Somova O.J., Gankovskaya O.A., Lavrov V.F., Gankovskaya L.V., Zverev V.V. Dynamics of expression of tlr9-mediated signaling by epithelial cells of the cervical canal under the influence of the herpes simplex virus type 2 in vitro. Russian Immunological Journal. 2011. T. 5. № 2 (14). P. 129—134.
  19. Alieva A.I., Omarova S.M., Svitich O.A., Absherkhanova D.U. Efficiency of modern criteria for diagnosis and rational antibiotic therapy of ventilator-associated pneumonias in newborns. Russian Immunological Journal. 2015. Vol. 9 (18). No. 2 (1). C. 120—122.
  20. Gankovskaya O.A. Molecular genetic mechanisms of congenital immunity at the level of mucous membranes in the pathology of infectious genesis: dis. Dr. med. sciences: 14.03.09. M., 2010. 300 p.
  21. Simbirtsev A.S., Gromov A.Yu. Polymorphism of genes of the human IL-1 family. Cytokines and inflammation. 2005. Т. 4. № 1.2. P. 3—10.

Copyright (c) 2018 Rasskazova N.D., Alieva A.I., Gankovskaya L.V., Zhigalkina P.V., Svitich O.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies